Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q81506299 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235816.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q81506299 | ||
| 024 | ‡a 0000-0002-9226-4470 ‡2 orcid | ||
| 024 | ‡a 36773199500 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q81506299 | ||
| 100 | 0 | ‡a Ren-Feng Li ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Ren-Feng Li ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. | ||
| 670 | ‡a Author's B Cell Receptor Activation and Chemical Induction Trigger Caspase-Mediated Cleavage of PIAS1 to Facilitate Epstein-Barr Virus Reactivation. | ||
| 670 | ‡a Author's Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. | ||
| 670 | ‡a Author's Differential ubiquitination of Smad1 mediated by CHIP: implications in the regulation of the bone morphogenetic protein signaling pathway. | ||
| 670 | ‡a Author's Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines | ||
| 670 | ‡a Author's Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction. | ||
| 670 | ‡a Author's Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling | ||
| 670 | ‡a Author's Potential of protein kinase inhibitors for treating herpesvirus-associated disease. | ||
| 670 | ‡a Author's SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. | ||
| 670 | ‡a Author's The Ying-Yang of the virus-host interaction: control of the DNA damage response. | ||
| 670 | ‡a Author's Understanding Epstein-Barr Virus Life Cycle with Proteomics: A Temporal Analysis of Ubiquitination During Virus Reactivation. | ||
| 909 | ‡a (scopus) 36773199500 ‡9 1 | ||
| 909 | ‡a (orcid) 0000000292264470 ‡9 1 | ||
| 919 | ‡a bcellreceptoractivationandchemicalinductiontriggercaspasemediatedcleavageofpias1tofacilitateepsteinbarrvirusreactivation ‡A B Cell Receptor Activation and Chemical Induction Trigger Caspase-Mediated Cleavage of PIAS1 to Facilitate Epstein-Barr Virus Reactivation. ‡9 1 | ||
| 919 | ‡a conservedherpesviruskinasestargetthednadamageresponsepathwayandtip60histoneacetyltransferasetopromotevirusreplication ‡A Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. ‡9 1 | ||
| 919 | ‡a yingyangofthevirushostinteractioncontrolofthednadamageresponse ‡A The Ying-Yang of the virus-host interaction: control of the DNA damage response. ‡9 1 | ||
| 919 | ‡a differentialubiquitinationofsmad1mediatedbychipimplicationsintheregulationofthebonemorphogeneticproteinsignalingpathway ‡A Differential ubiquitination of Smad1 mediated by CHIP: implications in the regulation of the bone morphogenetic protein signaling pathway. ‡9 1 | ||
| 919 | ‡a interferonregulatoryfactor8regulatescaspase1expressiontofacilitateepsteinbarrvirusreactivationinresponsetobcellreceptorstimulationandchemicalinduction ‡A Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction. ‡9 1 | ||
| 919 | ‡a sumobindingbytheepsteinbarrvirusproteinkinasebglf4iscrucialforbglf4function ‡A SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. ‡9 1 | ||
| 919 | ‡a potentialofproteinkinaseinhibitorsfortreatingherpesvirusassociateddisease ‡A Potential of protein kinase inhibitors for treating herpesvirus-associated disease. ‡9 1 | ||
| 919 | ‡a phosphoproteomicprofilingrevealsepsteinbarrvirusproteinkinaseintegrationofdnadamageresponseandmitoticsignaling ‡A Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling ‡9 1 | ||
| 919 | ‡a understandingepsteinbarrviruslifecyclewithproteomicsatemporalanalysisofubiquitinationduringvirusreactivation ‡A Understanding Epstein-Barr Virus Life Cycle with Proteomics: A Temporal Analysis of Ubiquitination During Virus Reactivation. ‡9 1 | ||
| 919 | ‡a proteinarrayscreenforkaposissarcomaassociatedherpesviruslanainteractorslinkslanatotip60pp2aactivityandtelomereshortening ‡A A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. ‡9 1 | ||
| 919 | ‡a immunoregulationwithmtorinhibitorstopreventcovid19severityanovelinterventionstrategybeyondvaccinesandspecificantiviralmedicines ‡A Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines ‡9 1 | ||
| 996 | ‡2 CAOONL|ncf11038952 | ||
| 996 | ‡2 NII|DA11215133 | ||
| 996 | ‡2 CYT|AC000650800 | ||
| 996 | ‡2 CAOONL|ncf13789860 | ||
| 996 | ‡2 ISNI|0000000063357665 | ||
| 996 | ‡2 LC|n 83209007 | ||
| 996 | ‡2 CAOONL|ncf11511564 | ||
| 996 | ‡2 ISNI|000000006428033X | ||
| 996 | ‡2 DNB|1024434176 | ||
| 996 | ‡2 LC|n 88063752 | ||
| 996 | ‡2 ISNI|0000000064192612 | ||
| 996 | ‡2 J9U|987007348238305171 | ||
| 996 | ‡2 LC|n 88238555 | ||
| 996 | ‡2 LC|n 99002126 | ||
| 996 | ‡2 CYT|AC000639334 | ||
| 996 | ‡2 DNB|1166779459 | ||
| 996 | ‡2 LC|nr 92017788 | ||
| 996 | ‡2 NTA|207215286 | ||
| 996 | ‡2 ISNI|0000000079816547 | ||
| 996 | ‡2 CYT|AC000635036 | ||
| 996 | ‡2 DNB|109835141X | ||
| 996 | ‡2 ISNI|0000000064299209 | ||
| 996 | ‡2 NUKAT|n 2009105351 | ||
| 996 | ‡2 ISNI|0000000064025179 | ||
| 996 | ‡2 NSK|000735743 | ||
| 996 | ‡2 ISNI|0000000064357368 | ||
| 996 | ‡2 CYT|AC000643469 | ||
| 996 | ‡2 LC|no2015134845 | ||
| 996 | ‡2 NII|DA09942102 | ||
| 996 | ‡2 BIBSYS|90672096 | ||
| 996 | ‡2 ISNI|0000000051460534 | ||
| 996 | ‡2 ISNI|0000000047030021 | ||
| 996 | ‡2 LC|no2013088354 | ||
| 996 | ‡2 ISNI|0000000079575819 | ||
| 996 | ‡2 SUDOC|061799262 | ||
| 996 | ‡2 NTA|426165594 | ||
| 996 | ‡2 NUKAT|n 96301070 | ||
| 996 | ‡2 BNF|16008098 | ||
| 996 | ‡2 SUDOC|135962137 | ||
| 996 | ‡2 LC|n 90601077 | ||
| 996 | ‡2 LC|no2009125695 | ||
| 996 | ‡2 ISNI|0000000064263775 | ||
| 996 | ‡2 NTA|16889629X | ||
| 996 | ‡2 CYT|AC000516860 | ||
| 996 | ‡2 ISNI|0000000064221460 | ||
| 996 | ‡2 CYT|AC000214811 | ||
| 996 | ‡2 CAOONL|ncf10287867 | ||
| 996 | ‡2 ISNI|0000000063508793 | ||
| 996 | ‡2 CYT|AC000506875 | ||
| 996 | ‡2 DNB|1052822851 | ||
| 996 | ‡2 NUKAT|n 2022200025 | ||
| 996 | ‡2 BNF|14437801 | ||
| 996 | ‡2 LC|n 82053578 | ||
| 996 | ‡2 SUDOC|230206174 | ||
| 996 | ‡2 PLWABN|9810660214705606 | ||
| 996 | ‡2 CAOONL|ncf11881570 | ||
| 996 | ‡2 BNF|17085683 | ||
| 996 | ‡2 LC|n 99002383 | ||
| 996 | ‡2 ISNI|0000000064109428 | ||
| 996 | ‡2 CYT|AC000639455 | ||
| 996 | ‡2 PLWABN|9811552892205606 | ||
| 996 | ‡2 CYT|AC000207418 | ||
| 996 | ‡2 DNB|1069225878 | ||
| 996 | ‡2 ISNI|0000000426618327 | ||
| 996 | ‡2 J9U|987007349813605171 | ||
| 996 | ‡2 ISNI|0000000111952785 | ||
| 996 | ‡2 LC|n 79125298 | ||
| 996 | ‡2 DNB|1292611855 | ||
| 996 | ‡2 ISNI|0000000106534087 | ||
| 996 | ‡2 SUDOC|263180247 | ||
| 996 | ‡2 ERRR|12374787 | ||
| 996 | ‡2 NII|DA1251774X | ||
| 996 | ‡2 LC|n 2018044709 | ||
| 996 | ‡2 SUDOC|230973175 | ||
| 996 | ‡2 CYT|AC000653261 | ||
| 996 | ‡2 LC|nr 94019729 | ||
| 996 | ‡2 LC|nr 92013139 | ||
| 996 | ‡2 DNB|1173284346 | ||
| 996 | ‡2 J9U|987007441117505171 | ||
| 996 | ‡2 ISNI|000000006334205X | ||
| 996 | ‡2 LC|nr 00015070 | ||
| 996 | ‡2 J9U|987007451318105171 | ||
| 996 | ‡2 SUDOC|234072113 | ||
| 996 | ‡2 LC|n 85362320 | ||
| 996 | ‡2 ISNI|000000006370329X | ||
| 996 | ‡2 ISNI|0000000117052251 | ||
| 996 | ‡2 CYT|AC000658782 | ||
| 996 | ‡2 ISNI|000000041838599X | ||
| 996 | ‡2 CYT|AC000632192 | ||
| 996 | ‡2 NII|DA11490160 | ||
| 996 | ‡2 DNB|102329981X | ||
| 996 | ‡2 LC|n 79121510 | ||
| 996 | ‡2 ISNI|0000000075459634 | ||
| 996 | ‡2 ISNI|0000000063886612 | ||
| 996 | ‡2 ISNI|0000000082854130 | ||
| 996 | ‡2 ISNI|000000003813745X | ||
| 996 | ‡2 ISNI|0000000044793322 | ||
| 996 | ‡2 LC|n 2006096021 | ||
| 996 | ‡2 DNB|1067795618 | ||
| 996 | ‡2 PLWABN|9810531390405606 | ||
| 996 | ‡2 CAOONL|ncf10356590 | ||
| 996 | ‡2 DNB|1186278994 | ||
| 996 | ‡2 ISNI|0000000037551499 | ||
| 996 | ‡2 NTA|364154691 | ||
| 996 | ‡2 PLWABN|9810666483905606 | ||
| 996 | ‡2 ISNI|000000006397097X | ||
| 996 | ‡2 ISNI|000000006435284X | ||
| 996 | ‡2 J9U|987007386683605171 | ||
| 996 | ‡2 CYT|AC000640317 | ||
| 996 | ‡2 NII|DA10768024 | ||
| 996 | ‡2 LC|nr 91008308 | ||
| 996 | ‡2 CYT|AC000643511 | ||
| 996 | ‡2 ISNI|0000000455276063 | ||
| 996 | ‡2 ISNI|0000000392647612 | ||
| 996 | ‡2 PLWABN|9811771553605606 | ||
| 996 | ‡2 LC|nb2007006314 | ||
| 996 | ‡2 ISNI|0000000064183118 | ||
| 996 | ‡2 BAV|495_228014 | ||
| 996 | ‡2 ISNI|0000000070464194 | ||
| 996 | ‡2 LC|nr 96031667 | ||
| 996 | ‡2 ISNI|0000000023354013 | ||
| 996 | ‡2 BIBSYS|32507 | ||
| 996 | ‡2 BIBSYS|3116179 | ||
| 996 | ‡2 NTA|323265480 | ||
| 996 | ‡2 BIBSYS|90281517 | ||
| 996 | ‡2 CYT|AC000635805 | ||
| 996 | ‡2 LC|n 83045830 | ||
| 996 | ‡2 ISNI|0000000075579206 | ||
| 996 | ‡2 LC|nr 91022840 | ||
| 996 | ‡2 DNB|109318339X | ||
| 996 | ‡2 BIBSYS|5019129 | ||
| 996 | ‡2 NTA|364154233 | ||
| 996 | ‡2 NTA|364154128 | ||
| 996 | ‡2 LC|n 2022049206 | ||
| 996 | ‡2 ISNI|0000000036426186 | ||
| 996 | ‡2 LC|n 2020069929 | ||
| 996 | ‡2 LC|n 84105198 | ||
| 996 | ‡2 ISNI|0000000063511925 | ||
| 996 | ‡2 J9U|987007310650105171 | ||
| 996 | ‡2 LC|n 88137810 | ||
| 996 | ‡2 LC|nb2014010623 | ||
| 996 | ‡2 J9U|987007345960405171 | ||
| 996 | ‡2 BNF|16896269 | ||
| 996 | ‡2 LC|nr 94019798 | ||
| 996 | ‡2 NTA|327885025 | ||
| 996 | ‡2 DNB|1056925744 | ||
| 996 | ‡2 DNB|1044570636 | ||
| 996 | ‡2 DNB|129423580 | ||
| 996 | ‡2 LC|n 90643389 | ||
| 996 | ‡2 SUDOC|07844750X | ||
| 996 | ‡2 LC|n 85282369 | ||
| 996 | ‡2 LC|n 2003002518 | ||
| 996 | ‡2 SUDOC|127661212 | ||
| 996 | ‡2 LC|no 89007036 | ||
| 996 | ‡2 NII|DA14526774 | ||
| 996 | ‡2 LC|nr 96022606 | ||
| 996 | ‡2 DNB|1081797304 | ||
| 996 | ‡2 LC|nr 96004658 | ||
| 996 | ‡2 CYT|AC000639496 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
